Type 1 diabetes patients have significantly lower frequency of plasmacytoid dendritic cells in the peripheral blood

Clinical Immunology

Volumn 129, Issue 3, 2008, Pages 413-418

  Chen, Xueqin ^a,b   Makala, Levi H C ^a   Jin, Yulan ^a   Hopkins, Diane ^a   Muir, Andy ^a   Garge, Nikhil ^a   Podolsky, Robert H ^a   She, Jin Xiong ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Autoimmunity; DC; Dendritic cells; Myeloid DC; Plasmacytoid DC; Type 1 diabetes

Indexed keywords

ADOLESCENT; ADULT; AGE; ARTICLE; BLOOD; CHILD; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CELL COUNT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DENDRITIC CELLS; DIABETES MELLITUS, TYPE 1; FEMALE; FLOW CYTOMETRY; HUMANS; INFANT; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 55249084154     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2008.08.013     Document Type: Article

References (37)

1. Green E.A., Choi Y., and Flavell R.A. Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals. Immunity 16 (2002) 183-191
2. Green E.A., Gorelik L., McGregor C.M., Tran E.H., and Flavell R.A. CD4+CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-beta-TGF-beta receptor interactions in type 1 diabetes. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 10878-10883
3. Liu Y.J., Kanzler H., Soumelis V., and Gilliet M. Dendritic cell lineage, plasticity and cross-regulation. Nat. Immunol. 2 (2001) 585-589
4. Wakkach A., Fournier N., Brun V., Breittmayer J.P., Cottrez F., and Groux H. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 18 (2003) 605-617
5. Moseman E.A., Liang X., Dawson A.J., Panoskaltsis-Mortari A., Krieg A.M., Liu Y.J., Blazar B.R., and Chen W. Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells. J. Immunol. 173 (2004) 4433-4442
6. Dzionek A., Fuchs A., Schmidt P., Cremer S., Zysk M., Miltenyi S., Buck D.W., and Schmitz J. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J. Immunol. 165 (2000) 6037-6046
7. Shortman K., and Liu Y.J. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2 (2002) 151-161
8. Lutz M.B., and Schuler G. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?. Trends Immunol. 23 (2002) 445-449
9. Nakano H., Yanagita M., and Gunn M.D. CD11c(+)B220(+)Gr-1(+) cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells. J. Exp. Med. 194 (2001) 1171-1178
10. Cella M., Jarrossay D., Facchetti F., Alebardi O., Nakajima H., Lanzavecchia A., and Colonna M. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat. Med. 5 (1999) 919-923
11. Siegal F.P., Kadowaki N., Shodell M., Fitzgerald-Bocarsly P.A., Shah K., Ho S., Antonenko S., and Liu Y.J. The nature of the principal type 1 interferon-producing cells in human blood. Science 284 (1999) 1835-1837
12. Martin P., Del Hoyo G.M., Anjuere F., Arias C.F., Vargas H.H., Fernandez L., Parrillas V., and Ardavin C. Characterization of a new subpopulation of mouse CD8alpha+ B220+ dendritic cells endowed with type 1 interferon production capacity and tolerogenic potential. Blood 100 (2002) 383-390
13. Abe M., Wang Z., de Creus A., and Thomson A.W. Plasmacytoid dendritic cell precursors induce allogeneic T-cell hyporesponsiveness and prolong heart graft survival. Am. J. Transplant. 5 (2005) 1808-1819
14. Moseman E.A., Liang X., Dawson A.J., Panoskaltsis-Mortari A., Krieg A.M., Liu Y.J., Blazar B.R., and Chen W. Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells. J. Immunol. 173 (2004) 4433-4442
15. Kared H., Masson A., Adle-Biassette H., Bach J.F., Chatenoud L., and Zavala F. Treatment with granulocyte colony-stimulating factor prevents diabetes in NOD mice by recruiting plasmacytoid dendritic cells and functional CD4(+)CD25(+) regulatory T-cells. Diabetes 54 (2005) 78-84
16. Saxena V., Ondr J.K., Magnusen A.F., Munn D.H., and Katz J.D. The countervailing actions of myeloid and plasmacytoid dendritic cells control autoimmune diabetes in the nonobese diabetic mouse. J. Immunol. 179 (2007) 5041-5053
17. Peng R., Li Y., Brezner K., Litherland S., and Clare-Salzler M.J. Abnormal peripheral blood dendritic cell populations in type 1 diabetes. Ann. N. Y. Acad. Sci. 1005 (2003) 222-225
18. Summers K.L., Marleau A.M., Mahon J.L., McManus R., Hramiak I., and Singh B. Reduced IFN-[alpha] secretion by blood dendritic cells in human diabetes. Clin. Immunol. 121 (2006) 81-89
19. Vuckovic S., Withers G., Harris M., Khalil D., Gardiner D., Flesch I., Tepes S., Greer R., Cowley D., Cotterill A., and Hart D.N.J. Decreased blood dendritic cell counts in type 1 diabetic children. Clin. Immunol. 123 (2007) 281-288
20. Vakkila J., Thomson A.W., Vettenranta K., Sariola H., and Saarinen-Pihkala U.M. Dendritic cell subsets in childhood and in children with cancer: relation to age and disease prognosis. Clin. Exp. Immunol. 135 (2004) 455-461
21. Takahashi K., Honeyman M.C., and Harrison L.C. Impaired yield, phenotype, and function of monocyte-derived dendritic cells in humans at risk for insulin-dependent diabetes2. J. Immunol. 161 (1998) 2629-2635
22. Spatz M., Eibl N., Hink S., Wolf H.M., Fischer G.F., Mayr W.R., Schernthaner G., and Eibl M.M. Impaired primary immune response in type-1 diabetes. Functional impairment at the level of APCs and T-cells1. Cell Immunol. 221 (2003) 15-26
23. Jansen A., van H.M., and Drexhage H.A. Defective maturation and function of antigen-presenting cells in type 1 diabetes1. Lancet 345 (1995) 491-492
24. Eibl N., Spatz M., Fischer G.F., Mayr W.R., Samstag A., Wolf H.M., Schernthaner G., and Eibl M.M. Impaired primary immune response in type-1 diabetes: results from a controlled vaccination study2. Clin. Immunol. 103 (2002) 249-259
25. Zacher T., Knerr I., Rascher W., Kalden J.R., and Wassmuth R. Characterization of monocyte-derived dendritic cells in recent-onset diabetes mellitus type 11. Clin. Immunol. 105 (2002) 17-24
26. Teig N., Moses D., Gieseler S., and Schauer U. Age-related changes in human blood dendritic cell subpopulations. Scand. J. Immunol. 55 (2002) 453-457
27. Robak E., Smolewski P., Wozniacka A., Sysa-Jedrzejowska A., Stepien H., and Robak T. Relationship between peripheral blood dendritic cells and cytokines involved in the pathogenesis of systemic lupus erythematosus. Eur. Cytokine Netw. 15 (2004) 222-230
28. Tucci M., Calvani N., Richards H.B., Quatraro C., and Silvestris F. The interplay of chemokines and dendritic cells in the pathogenesis of lupus nephritis. Ann. N. Y. Acad. Sci. 1051 (2005) 421-432 421-32
29. Robak E., Smolewski P., Wozniacka A., Sysa-Jedrzejowska A., Stepien H., and Robak T. Relationship between peripheral blood dendritic cells and cytokines involved in the pathogenesis of systemic lupus erythematosus. Eur. Cytokine Netw. 15 (2004) 222-230
30. Ito T., Liu Y.J., and Kadowaki N. Functional diversity and plasticity of human dendritic cell subsets. Int. J. Hematol. 81 (2005) 188-196
31. Kuwana M. Induction of anergic and regulatory T cells by plasmacytoid dendritic cells and other dendritic cell subsets. Hum. Immunol. 63 (2002) 1156-1163
32. Kuwana M., Kaburaki J., Wright T.M., Kawakami Y., and Ikeda Y. Induction of antigen-specific human CD4(+) T cell anergy by peripheral blood DC2 precursors. Eur. J. Immunol. 31 (2001) 2547-2557
33. Moseman E.A., Liang X., Dawson A.J., Panoskaltsis-Mortari A., Krieg A.M., Liu Y.J., Blazar B.R., and Chen W. Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells. J. Immunol. 173 (2004) 4433-4442
34. Gilliet M., and Liu Y.J. Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J. Exp. Med. 195 (2002) 695-704
35. Sharma M.D., Baban B., Chandler P., Hou D.Y., Singh N., Yagita H., Azuma M., Blazar B.R., Mellor A.L., and Munn D.H. Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase. J. Clin. Invest. 117 (2007) 2570-2582
36. Brusko T.M., Wasserfall C.H., Clare-Salzler M.J., Schatz D.A., and Atkinson M.A. Functional defects and the influence of age on the frequency of CD4+ CD25+ T-cells in type 1 diabetes. Diabetes 54 (2005) 1407-1414
37. Lindley S., Dayan C.M., Bishop A., Roep B.O., Peakman M., and Tree T.I. Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes. Diabetes 54 (2005) 92-99